Most Read News

In the second quarter, EBITDA increased by 27.5% to ₹813.8 Crore, with an EBITDA margin of 61.7%, up from 52.4% the year before.

The total IPO size is ₹260.04 Crore, with ₹217.21 Crore raised from the issuance of fresh shares and ₹42.83 Crore allocated for the OFS.

The price band for the IPO has been set between ₹1427 to ₹1503 per equity share.

Alembic Pharmaceuticals continues to grow its footprint in the US, with this approval contributing to its robust portfolio of generic medications.

As of October 18, foreign investors had sold ₹77,000 crore worth of Indian stocks, the most they had ever sold in a single month.

Gaurav Gogoi, the MP for Jorhat, praised the board's decision but emphasized the importance of doing a thorough analysis of the circumstances.

The companies plan to utilize existing production facilities in Chakan, Pune, owned by both SAVWIPL and Mahindra, for the manufacturing of these new vehicles.

The SBI Nifty India Consumption Index Fund offers an opportunity to participate in consumption theme, passively

In a volatile month, there was some interesting buy and sell action seen in mutual funds in September 2024

The gross non-performing asset (GNPA) ratio was 3.18% in the September quarter, compared to 3.32% in the June quarter.